node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
LOC102695073 | W5LWR7_LEPOC | ENSLOCP00000012097 | ENSLOCP00000000574 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Peptidase_M16_M domain-containing protein. | 0.841 |
LOC102695073 | W5NDH1_LEPOC | ENSLOCP00000012097 | ENSLOCP00000018680 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin-like growth factor 1. | 0.835 |
LOC102695073 | W5NLK8_LEPOC | ENSLOCP00000012097 | ENSLOCP00000021517 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 1. | 0.892 |
LOC102695073 | egf | ENSLOCP00000012097 | ENSLOCP00000014477 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Epidermal growth factor. | 0.888 |
LOC102695073 | ide | ENSLOCP00000012097 | ENSLOCP00000008596 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin-degrading enzyme; Belongs to the peptidase M16 family. | 0.948 |
LOC102695073 | igf1r | ENSLOCP00000012097 | ENSLOCP00000017791 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Tyrosine-protein kinase receptor. | 0.943 |
LOC102695073 | insr | ENSLOCP00000012097 | ENSLOCP00000005036 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Tyrosine-protein kinase receptor. | 0.943 |
LOC102695073 | met | ENSLOCP00000012097 | ENSLOCP00000019200 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | MET proto-oncogene, receptor tyrosine kinase. | 0.900 |
LOC102695073 | mst1r | ENSLOCP00000012097 | ENSLOCP00000013339 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Macrophage stimulating 1 receptor b. | 0.900 |
LOC102695073 | nrdc | ENSLOCP00000012097 | ENSLOCP00000012064 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Nardilysin b (N-arginine dibasic convertase); Belongs to the peptidase M16 family. | 0.841 |
W5LWR7_LEPOC | LOC102695073 | ENSLOCP00000000574 | ENSLOCP00000012097 | Peptidase_M16_M domain-containing protein. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.841 |
W5NDH1_LEPOC | LOC102695073 | ENSLOCP00000018680 | ENSLOCP00000012097 | Insulin-like growth factor 1. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.835 |
W5NDH1_LEPOC | egf | ENSLOCP00000018680 | ENSLOCP00000014477 | Insulin-like growth factor 1. | Epidermal growth factor. | 0.863 |
W5NDH1_LEPOC | igf1r | ENSLOCP00000018680 | ENSLOCP00000017791 | Insulin-like growth factor 1. | Tyrosine-protein kinase receptor. | 0.887 |
W5NDH1_LEPOC | insr | ENSLOCP00000018680 | ENSLOCP00000005036 | Insulin-like growth factor 1. | Tyrosine-protein kinase receptor. | 0.876 |
W5NLK8_LEPOC | LOC102695073 | ENSLOCP00000021517 | ENSLOCP00000012097 | Insulin receptor substrate 1. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.892 |
W5NLK8_LEPOC | igf1r | ENSLOCP00000021517 | ENSLOCP00000017791 | Insulin receptor substrate 1. | Tyrosine-protein kinase receptor. | 0.973 |
W5NLK8_LEPOC | insr | ENSLOCP00000021517 | ENSLOCP00000005036 | Insulin receptor substrate 1. | Tyrosine-protein kinase receptor. | 0.972 |
W5NLK8_LEPOC | met | ENSLOCP00000021517 | ENSLOCP00000019200 | Insulin receptor substrate 1. | MET proto-oncogene, receptor tyrosine kinase. | 0.630 |
W5NLK8_LEPOC | mst1r | ENSLOCP00000021517 | ENSLOCP00000013339 | Insulin receptor substrate 1. | Macrophage stimulating 1 receptor b. | 0.630 |